RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000147.xml
Allgemein- und Viszeralchirurgie up2date 2016; 10(05): 369-394
DOI: 10.1055/s-0042-110842
DOI: 10.1055/s-0042-110842
Leber, Galle, Pankreas, Milz
Echinokokkosen der Leber
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
13. Oktober 2016 (online)
![](https://www.thieme-connect.de/media/avc-u2d/201605/lookinside/thumbnails/10-1055-s-0042-110842_av1762955_henne-bruns-1.jpg)
Die Echinokokkosen des Menschen sind Zoonosen als Folge einer Infektion mit den Larvenstadien der Gattung Echinococcus, bei denen der Mensch als Fehlzwischenwirt fungiert. Für Mitteleuropa bzw. Deutschland humanmedizinisch relevant sind
• die zystische Echinokokkose – Hundebandwurmerkrankung, verursacht durch Echinococcus granulosus – und
• die alveoläre Echinokokkose – Fuchsbandwurmerkrankung, verursacht durch Echinococcus multilocularis.
Da das Wachstumsverhalten der beiden Spezies im Menschen sehr unterschiedlich ist, resultieren 2 in Diagnostik, Therapie und Prognose verschiedene Erkrankungen, weswegen die beiden Krankheitsbilder hier separat vorgestellt werden sollen.
-
Literatur
- 1 Eckert J, Deplazes P. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin Microbiol Rev 2004; 17: 107-135
- 2 Robert Koch-Institut. Epidemiologisches Bulletin: Echinokokkose. Berlin: RKI; 2005
- 3 Romig T. Epidemiology of echinococcosis. Langenbecks Arch Surg 2003; 4: 209-217
- 4 Romig T, Kratzer W, Kimmig P. An epidemiological survey of human alveolar echinococcosis in southwestern Germany. Am J Trop Med Hyg 1999; 61: 566-773
- 5 Torgerson P, Keller K, Magnotta M et al. The global burden of alveolar echinococcosis. PLoS Negl Trop Dis 2010; 4: e722
- 6 Craig P. Epidemiology of human alveolar echinococcosis in China. Parasitol Int 2005; 55 (Suppl. 01) S221-S225
- 7 Robert Koch-Institut. SurvStat@RKI 2.0: Alveoläre und Zystische Echinokokkose in Deutschland 2015. Im Internet: http://www.survstat.rki.de/Content/Query/Create.aspx Stand: September 2016
- 8 Nothdurft H, Jelinek T, Mai A et al. Epidemiologie der Echinokokkose in Bayern. Dtsch Med Wochenschr 1995; 120: 1151-1155
- 9 Eckert J. The “dangerous fox tapeworm” (Echinococcus multilocularis) and alveolar echinococcosis of humans in central Europe. Berl Münch Tierärztl Wochenschr 1996; 109: 202-210
- 10 Piarroux M, Piarroux R, Knapp J et al. Populations at risk for alveolar echinococcosis, France. Emerg Infect Dis 2013; 19: 721-728
- 11 Kern P, Bardonnet K, Renner E et al. European Echinococcosis Registry: Human alveolar echinococcosis, Europe, 1982–2000. Emerg Infect Dis 2003; 9: 343-349
- 12 Ammann RW. Cestodes. Echinococcus. Gastroenterol Clin North Am 1996; 25: 655
- 13 Pawlowski Z, Eckert J, Vuitton D. WHO/OIE Manual on echinococcosis in humans and animals: a public health problem of global concern: Echinococcosis in humans: clinical aspects, diagnosis and treatment. Im Internet: http://apps.who.int/iris/bitstream/10665/42427/1/929044522X.pdf Stand: September 2016
- 14 Reuter S, Seitz HM, Kern P et al. Extrahepatic alveolar echinococcosis without liver involvement: a rare manifestation. Infection 2000; 28: 187-192
- 15 Bresson-Hadni S, Laplante J, Lenys D et al. Seroepidemiologic screening of Echinococcus multilocularis infection in an European area endemic for alveolar echinococcosis. Am J Trop Med Hyg 1994; 51: 837
- 16 Kern P. Clinical features and treatment of alveolar echinococcosis. Curr Opin Infect Dis 2010; 23: 505-512
- 17 Piarroux M, Piarroux R, Giorgi R et al. Clinical features and evolution of alveolar echinococcosis in France from 1982 to 2007: Results of a survey in 387 patients. J Hepatol 2011; 55: 1025-1033
- 18 Brunetti E, Kern P, Vuitton D. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Tropica 2009; 114: 1-16
- 19 Kern P, Kurz S, Beurton I et al. Alveoläre Echinokokkose. Entwicklung und Vorschlag einer klinischen Klassifikation in Anlehnung an das TNM-System. Chemother J 2002; 11: 151-153
- 20 Kern P, Wen H, Sato N et al. WHO classification of alveolar echinococcosis: Principles and application. Parasitol Int 2005; 55: S283-S287
- 21 Frosch M. Labordiagnose der zystischen und alveolären Echinokokkose. J Lab Med 2003; DOI: 10.1046/j.1439-0477.2003.03072.x.
- 22 Reiter-Owona I, Grüner B, Frosch M et al. Serological confirmatory testing of alveolar and cystic echinococcosis in clinical practice: results of a comparative study with commercialized and in-house assays. Clin Lab 2009; 55: 41-48
- 23 Kratzer W, Grüner B, Kaltenbach T et al. Proposal of an ultrasonographic classification for hepatic alveolar echinococcosis: Echinococcosis multilocularis Ulm classification – ultrasound. World J Gastroenterol 2015; 21: 12392-12402
- 24 Graeter T, Kratzer W, Oeztuerk S et al. Proposal of a computed tomography classification for hepatic alveolar echinococcosis. World J Gastroenterol 2016; 22: 3621-3631
- 25 Vuitton D, Bresson-Hadni S. Alveolar echinococcosis: Evaluation of therapeutic strategies. Expert Opinion on Orphan Drugs 2014; 2: 67-86
- 26 Vuitton D. Benzimidazoles for the treatment of cystic and alveolar echinococcosis: What is the consensus?. Expert Rev Anti-Infect Ther 2014; 7: 145-149
- 27 Reuter S, Buck A, Manfras B et al. Structured treatment interruption in patients with alveolar echinococcosis. Hepatology 2004; 39: 509-517
- 28 Reuter S, Gruener B, Buck A et al. Long-term follow-up of metabolic activity in human alveolar echinococcosis using FDG-PET. Nuklearmedizin 2008; 4: 139-177
- 29 Ammann R, Stumpe KDM, Grimm F et al. Outcome after discontinuing long-term benzimidazole treatment in 11 patients with non-resectable alveolar echinococcosis with negative FDG-PET/CT and anti-EmII/3-10 serology. PLoS Negl Trop Dis 2015; 9: e0003964
- 30 Kadry Z, Renner EC, Bachmann LM et al. Evaluation of treatment and long-term follow-up in patients with hepatic alveolar echinococcosis. Br J Surg 2005; 92: 1110-1116
- 31 Brunetti E, Kern P, Vuitton D. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Tropica 2009; 114: 1-16
- 32 Buttenschoen K, Kern P, Reuter S et al. Hepatic infestation of Echinococcus multilocularis with extension to regional lymph nodes. Langenbecks Arch Surg 2009; 394: 699-704
- 33 Torgerson P, Macpherson C. The socioeconomic burden of parasitic zoonoses: global trends. Vet Parasitol 2011; 182: 79-95
- 34 Tappe D, Zidowitz S, Demmer P et al. Three-dimensional reconstruction of echinococcus multilocularis larval growth in human hepatic tissue reveals complex growth patterns. Am J Tropical Med Hyg 2010; 82: 126-127
- 35 Barth T, Herrmann T, Tappe D et al. Sensitive and specific immunohistochemical diagnosis of human alveolar echinococcosis with the monoclonal antibody Em2G11. PLoS Negl Trop Dis 2012; 6: e1877
- 36 Torgerson P, Schweiger A, Deplazes P et al. Alveolar echinococcosis: From a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years. J Hepatol 2008; 49: 72-77
- 37 Bresson-Hadni S, Koch S, Miguet J et al. Indications and results of liver transplantation for Echinococcus alveolar infection: an overview. Langenbecks Arch Surg 2003; 388: 231-238
- 38 Chauchet A, Grenouillet F, Knapp J et al. Increased incidence and characteristics of alveolar echinococcosis in patients with immunosuppression-associated conditions. Clin Infect Dis 2014; 59: 1095-1104
- 39 Conchedda M, Antonelli A, Caddori A et al. A retrospective analysis of human cystic echinococcosis in Sardinia (Italy), an endemic Mediterranean region, from 2001 to 2005. Parasitol Int 2010; 59: 454-459
- 40 Eckert J, Schantz P, Gasser R et al. Geographic Distribution and Prevalence. In: Eckert J, Gemmell MA, Meslin FX, Pawłowski ZS, eds. WHO/OIE Manual on Echinococcosis in Humans and Animals: a public Health Problem of global Concern. Paris: WHO; 2001: 100-142
- 41 Caremani M, Maestrini R, Occhini U et al. Echographic epidemiology of cystic hydatid disease in Italy. Eur J Epidemiol 1993; 9: 401-404
- 42 Frider B, Larrieu E, Odriozola M. Long-term outcome of asymptomatic liver hydatidosis. J Hepatol 1999; 30: 228-231
- 43 Tabain I, Sviben M, Ljubin-Sternak S et al. Seroprevalence of echinococcus granulosus infection in Croatian patients with cystic liver disease. J Helminthol 2011; 85: 192-195
- 44 Macpherson C, Milner R. Performance characteristics and quality control of community based ultrasound surveys for cystic and alveolar echinococcosis. Acta Tropica 2003; 85: 203-209
- 45 Larssen TB, Rørvik J, Hoff SR et al. The occurrence of asymptomatic and symptomatic simple hepatic cysts. A prospective, hospital-based study. Clin Radiol 2005; 60: 1026-1029
- 46 Liang P, Cao B, Wang Y et al. Differential diagnosis of hepatic cystic lesions with gray-scale and color Doppler sonography. J Clin Ultrasound 2005; 33: 100-105
- 47 Kilimcioğlu A, Özkol M, Bayındır P et al. The value of ultrasonography alone in screening surveys of cystic echinococcosis in children in Turkey. Parasitol Int 2006; 55: 273-275
- 48 Junghanss T, da Silva A, Horton J et al. Clinical management of cystic echinococcosis: state of the art, problems, and perspectives. Am J Trop Med Hyg 2008; 79: 301-311
- 49 Menezes da Silva A. Hydatid cyst of the liver – criteria for the selection of appropriate treatment. Acta Tropica 2003; 85: 237-242
- 50 Kodama Y, Fujita N, Shimizu T et al. Alveolar echinococcosis: MR findings in the liver. Radiology 2003; 228: 172-177